These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34423843)

  • 1. Dopamine D1R Receptor Stimulation as a Mechanistic Pro-cognitive Target for Schizophrenia.
    Abi-Dargham A; Javitch JA; Slifstein M; Anticevic A; Calkins ME; Cho YT; Fonteneau C; Gil R; Girgis R; Gur RE; Gur RC; Grinband J; Kantrowitz J; Kohler C; Krystal J; Murray J; Ranganathan M; Santamauro N; Van Snellenberg J; Tamayo Z; Wolf D; ; Gray D; Lieberman J
    Schizophr Bull; 2022 Jan; 48(1):199-210. PubMed ID: 34423843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
    Arnsten AF; Girgis RR; Gray DL; Mailman RB
    Biol Psychiatry; 2017 Jan; 81(1):67-77. PubMed ID: 26946382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach to evaluate the pharmacodynamics of a selective dopamine D1/D5 receptor partial agonist (PF-06412562) in patients with stable schizophrenia.
    Arce E; Balice-Gordon R; Duvvuri S; Naylor M; Xie Z; Harel B; Kozak R; Gray DL; DeMartinis N
    J Psychopharmacol; 2019 Oct; 33(10):1237-1247. PubMed ID: 31264510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of G protein-biased agonists that fail to recruit β-arrestin or promote internalization of the D1 dopamine receptor.
    Conroy JL; Free RB; Sibley DR
    ACS Chem Neurosci; 2015 Apr; 6(4):681-92. PubMed ID: 25660762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Neurofunctional Domains Approach to Evaluate D1/D5 Dopamine Receptor Partial Agonism on Cognition and Motivation in Healthy Volunteers With Low Working Memory Capacity.
    Balice-Gordon R; Honey GD; Chatham C; Arce E; Duvvuri S; Naylor MG; Liu W; Xie Z; DeMartinis N; Harel BT; Braley GH; Kozak R; Park L; Gray DL
    Int J Neuropsychopharmacol; 2020 May; 23(5):287-299. PubMed ID: 32055822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel dopamine D1 receptor agonist excites delay-dependent working memory-related neuronal firing in primate dorsolateral prefrontal cortex.
    Wang M; Datta D; Enwright J; Galvin V; Yang ST; Paspalas C; Kozak R; Gray DL; Lewis DA; Arnsten AFT
    Neuropharmacology; 2019 May; 150():46-58. PubMed ID: 30858103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia.
    Girgis RR; Van Snellenberg JX; Glass A; Kegeles LS; Thompson JL; Wall M; Cho RY; Carter CS; Slifstein M; Abi-Dargham A; Lieberman JA
    J Psychopharmacol; 2016 May; 30(5):428-35. PubMed ID: 26966119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cooperative roles of the dopamine receptors, D1R and D5R, on the regulation of renal sodium transport.
    Gildea JJ; Shah IT; Van Sciver RE; Israel JA; Enzensperger C; McGrath HE; Jose PA; Felder RA
    Kidney Int; 2014 Jul; 86(1):118-26. PubMed ID: 24552847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of pyrimidone D1 dopamine receptor positive allosteric modulators.
    Luderman KD; Jain P; Benjamin Free R; Conroy JL; Aubé J; Sibley DR; Frankowski KJ
    Bioorg Med Chem Lett; 2021 Jan; 31():127696. PubMed ID: 33221389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3β Interacts with Dopamine D1 Receptor to Regulate Receptor Function: Implication for Prefrontal Cortical D1 Receptor Dysfunction in Schizophrenia.
    Wang JR; Sun PH; Ren ZX; Meltzer HY; Zhen XC
    CNS Neurosci Ther; 2017 Feb; 23(2):174-187. PubMed ID: 27996211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine's Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders.
    Arnsten AF; Wang M; Paspalas CD
    Pharmacol Rev; 2015 Jul; 67(3):681-96. PubMed ID: 26106146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D1 receptor in medial prefrontal cortex mediates the effects of TAAR1 activation on chronic stress-induced cognitive and social deficits.
    Sun M; Zhang Y; Zhang XQ; Zhang Y; Wang XD; Li JT; Si TM; Su YA
    Neuropsychopharmacology; 2024 Jul; 49(8):1341-1351. PubMed ID: 38658737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurochemical arguments for the use of dopamine D
    Huang M; Kwon S; He W; Meltzer HY
    Pharmacol Biochem Behav; 2017 Jun; 157():16-23. PubMed ID: 28455126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists.
    Li H; Mirabel R; Zimmerman J; Ghiviriga I; Phidd DK; Horenstein N; Urs NM
    ACS Chem Neurosci; 2022 Jun; 13(12):1818-1831. PubMed ID: 35658399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective dopamine D
    Nesbit MO; Chai A; Axerio-Cilies P; Phillips AG; Wang YT; Held K
    Neuropharmacology; 2022 Apr; 207():108967. PubMed ID: 35077763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The allosteric dopamine D1 receptor potentiator, DETQ, ameliorates subchronic phencyclidine-induced object recognition memory deficits and enhances cortical acetylcholine efflux in male humanized D1 receptor knock-in mice.
    Meltzer HY; Rajagopal L; Matrisciano F; Hao J; Svensson KA; Huang M
    Behav Brain Res; 2019 Apr; 361():139-150. PubMed ID: 30521930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of cognitive impairments induced by GABA hypofunction in the male rat prefrontal cortex by direct and indirect dopamine D
    Auger ML; Meccia J; Phillips AG; Floresco SB
    Neuropharmacology; 2020 Jan; 162():107844. PubMed ID: 31704272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat.
    Lanza K; Chemakin K; Lefkowitz S; Saito C; Chambers N; Bishop C
    Psychopharmacology (Berl); 2020 Jan; 237(1):155-165. PubMed ID: 31435690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics.
    Felsing DE; Jain MK; Allen JA
    Curr Top Med Chem; 2019; 19(16):1365-1380. PubMed ID: 31553283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of human D1 and D5 dopaminergic G protein-coupled receptors: lessons from mutagenesis of a conserved serine residue in the cytosolic end of transmembrane region 6.
    Plouffe B; Tiberi M
    Methods Mol Biol; 2013; 964():141-80. PubMed ID: 23296783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.